RYAM Q1 2026 Earnings Significant EPS Miss Overshadowed by Modest Stock Gain Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development GT Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment CPIX Q1 2026 Earnings Narrowing Losses and Strategic Progress Amidst Revenue Challenges CNR Q1 2026 Earnings EPS Surprises to the Upside Shares Rally PBR Q1 2026 Earnings EPS Miss Amid Operational Headwinds GLP Q1 2026 Earnings Massive EPS Surprise of 455 Overshadows Lack of Revenue Disclosure JVA Q4 2019 Earnings Significant EPS Miss Stock Rises Modestly EDAP Q4 2025 Earnings EPS Misses Estimates Stock Rises Amid Strategic Progress AVTR Q1 2026 Earnings EPS Beats Estimates Stock Rises CLNN Q1 2026 Earnings Narrower Loss Surprises Analysts as Company Advances Neurological Pipeline SMPL Q1 2026 Earnings EPS Beat Drives Stock Higher BRN Q4 2024 Earnings Loss Reported Amid Challenging Energy Environment